Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Drug Giant Novartis Attempts to Block Generic Drugs in India

HeadlineJan 30, 2007

Protests were held in Washington and New Delhi, India, on Monday against the pharmaceutical giant Novartis. The company is seeking to overturn an Indian law regarding drug patents. Demonstrators say that if Norvatis wins the lawsuit, it will threaten India’s ability to manufacture low-cost generic drugs that are distributed throughout the Global South to treat AIDS and other diseases. Monique Wanjala spoke in New Delhi.

Monique Wanjala: “I have been living with HIV for the last, this is 13 years now, and I have been on treatment on ARVs since 2004, and this is because access has been made easier. And we are saying that if Novartis go through with this case, what does it mean to us as people living with HIV? It means that our lives are at stake.”

In Washington, activists from the Global AIDS Alliance tried to deliver a mini coffin to the downtown office of Novartis.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation